Structural genomics in endocrinology
Related Experiment Video
Updated: Oct 3, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
1Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, C4-R, PO Box 9600, 3500 RC Leiden, The Netherlands.
Abstract:
Traditionally, endocrine research evolved from the phenotypical characterisation of endocrine disorders to the identification of underlying molecular pathophysiology. This approach has been, and still is, extremely successful. The introduction of genomics and proteomics has resulted in a reversal of this sequence of endocrine research: reverse endocrinology. This approach has provided endocrinology with powerful tools to dissect novel molecular pathways involved in health and disease and to identify new drug targets, like the peroxisome-proliferator activated receptor (PPAR) nuclear receptor family. The reiterative combination of innovative genomics and proteomics, and classical endocrine approaches will enable maintenance of endocrinology as a front-runner in biological research and innovate therapeutical approaches in a continuing interaction between bed and bench.
Related Concept Videos
Genomics
Pharmacogenomics: Identification of New Drug Targets
Structures of the Endocrine System
Pharmacogenetics and Pharmacogenomics: Overview
Endocrine Signaling
Endocrine Signaling
